Redhill Biopharma
RDHL
#9732
Rank
โ‚ฌ9.61 M
Marketcap
7,51ย โ‚ฌ
Share price
-1.23%
Change (1 day)
4.81%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): โ‚ฌ6.97 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are โ‚ฌ35.74 Million. In 2022 the company made an earning of -โ‚ฌ66.89 Million, an increase over its 2021 earnings that were of -โ‚ฌ91.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚ฌ6.97 M-110.43%
2022 -โ‚ฌ66.89 Million-26.68%
2021 -โ‚ฌ91.22 Million28.32%
2020 -โ‚ฌ71.09 Million80.06%
2019 -โ‚ฌ39.48 Million8.97%
2018 -โ‚ฌ36.23 Million-14.76%
2017 -โ‚ฌ42.51 Million55.07%
2016 -โ‚ฌ27.41 Million39.26%
2015 -โ‚ฌ19.69 Million96.9%
2014 -โ‚ฌ10 Million0.78%
2013 -โ‚ฌ9.92 Million16.93%
2012 -โ‚ฌ8.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.91 B 63,915.21%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ15.38 B 142,399.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.89 B 35,942.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ40.8 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ0.77 B 7,046.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel